In our ongoing efforts to identify effective naturally sourced agents for the treating of diabetic complications, two new ( and ) and 11 known phenolic compounds (-) were isolated from an 80 % ethanol extract of leaves. The structures of the new compounds were established by spectroscopic and chemical studies. These isolates (-) were subjected to an bioassay evaluating their inhibitory activity on advanced glycation end products formation and rat lens aldose reductase activity. Of the compounds evaluated, the flavonoids (-, and ) markedly inhibited advanced glycation end products formation, with IC values of 7.4-72.0 µM, compared with the positive control, aminoguanidine (IC = 975.9 µM). In the rat lens aldose reductase assay, consistent with the inhibition of advanced glycation end products formation, the flavonoids (-, and ) exhibited considerable inhibition of rat lens aldose reductase activity, with IC values of 1.1-12.5 µM. In addition, the effects of kaempferol () and tiliroside () on the dilation of hyaloid-retinal vessels induced by high glucose in larval zebrafish were investigated. Only kaempferol significantly reduced the diameters of high glucose-induced hyaloid-retinal vessels, by 52.2 % at 10 µM, compared with those in the high glucose-treated control group.